Results 201 to 210 of about 2,088,860 (358)

Rural-urban differences in substance use during pregnancy. [PDF]

J Rural Health
Boswell EK, Hinds OM, Odahowski C, Crouch E, Hung P, Andrews CM.   +5 more
europepmc   +1 more source

Screening for new nematocidal substances of microbial origin by a new method using the pine wood nematode.

, 1988
Kazuhiko Otoguro, Zhong‐Xun Liu, Keiko FUKUDA, Yin Li, YUZURU IWAI, Haruo Tanaka, Satoshi Ōmura   +6 more
openalex   +2 more sources

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

Alcohol vs. Cocaine: Impulsivity and Alexithymia in Substance Use Disorder. [PDF]

Behav Sci (Basel)
Mosca A, Bubbico G, Cavallotto C, Chiappini S, Allegretti R, Miuli A, Marrangone C, Ciraselli N, Pettorruso M, Martinotti G.   +9 more
europepmc   +1 more source

Toxicity assessments of chemical substances using primary culture of rat hepatocytes.

, 1986
Jin Fang, Yasuhisa Kitagawa, Shinsuke Ishikawa, Hiroyuki Yanagisawa, Katsuyuki Nakajima, Shigeo Manabe, Osamu Wada   +6 more
openalex   +2 more sources

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Abuse of gabapentinoids in individuals with substance use disorders. [PDF]

J Forensic Sci
Sağlam İ, Aslan R, Akgür SA, Kurtulmuş Y.   +3 more
europepmc   +1 more source

A760 PATIENTS WITH A SUBSTANCE ABUSE HISTORY CAN EFFECTIVELY USE PCA [PDF]

, 1990
Brett R. Stacey, Michael C. Brody, DR Burke   +2 more
openalex   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

Molecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed, Lucas Mani, Muhammad Bilal Mirza, Ashtyn McAdoo, Takahito Kondo, Hidenori Tanaka, Nicole Meeks, Eben Rosenthal, Marisa Hom   +8 more
wiley   +1 more source

Examining Vaping Policies in Substance Use Disorder Treatment Facilities. [PDF]

Tob Use Insights
Ware OD, Geiger GR, Bautista TG, Baca-Atlas MH.   +3 more
europepmc   +1 more source